Patents by Inventor Robert Sanchez
Robert Sanchez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20200245676Abstract: A cigar holder is adapted to engage with a golf accessory holder provided in the dashboard, or other portion, of a golf cart. The golf accessory holder can take the form or a golf ball holder or a golf tee holder. In general the cigar holder includes an interfacing portion that is configured to engage the golf accessory holder, taking the place of the golf accessory for which the golf accessory holder is configured. There is also a wind shield portion extending upward from the lower interfacing portion, and a cigar holder portion that extends laterally from the wind shield portion.Type: ApplicationFiled: February 5, 2019Publication date: August 6, 2020Inventors: Eric M. Jubeck, Romulus Robert Sanchez, Lauren A. Oishi
-
Patent number: 10660898Abstract: This invention relates to the use of benzimidazole derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3? OH kinase family (hereinafter PI3 kinases), suitably, PI3K?, PI3K?, PI3K?, and/or PI3K?. Suitably, the present invention relates to the use of benzimidazoles in the treatment of one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries. More suitably, the present invention relates to PI3K? selective benzimidazoles compounds for treating cancer.Type: GrantFiled: April 24, 2019Date of Patent: May 26, 2020Assignee: GLAXOSMITHKLINE LLCInventors: Rosanna Tedesco, Junya Qu, Robert Sanchez, Ralph A. Rivero
-
Patent number: 10588891Abstract: The present invention relates to pyrrolidine sulfonamide analogs, pharmaceutical compositions containing them and their use as TRPV4 antagonists.Type: GrantFiled: September 20, 2017Date of Patent: March 17, 2020Assignee: GlaxoSmithKline Intellectual Property Development LimitedInventors: Edward J. Brnardic, Carl A. Brooks, Brian Griffin Lawhorn, Guosen Ye, Linda S. Barton, Brian W. Budzik, Jay M. Matthews, John Jeffrey McAtee, Jaclyn R. Patterson, Joseph E. Pero, Robert Sanchez, Matthew Robert Sender, Lamont Roscoe Terrell, David J. Behm, James V. Thomas
-
Publication number: 20190388274Abstract: Apparatuses, systems, and methods for treating tissue abnormalities are disclosed. The tissue may be visualized for determining a presence of one or more abnormalities contained therein. Imaging data obtained by visualization may be used to determine the presence of one or more abnormalities. Each of the detected abnormalities may be identified and a treatment plan developed for treating the abnormalities. Treatment may be delivered to the abnormalities according to the treatment plan.Type: ApplicationFiled: September 4, 2019Publication date: December 26, 2019Inventors: Michael John Claus, Robert Sanchez, Tammo Heeren, Argelio Michael Olivera, Michael Papac, Lingfeng Yu, Hugang Ren
-
Publication number: 20190314190Abstract: A system suitable for collecting and transporting urine away from the body of a person or animal may include an assembly having a fluid impermeable casing having a fluid reservoir at a first end, a fluid outlet at a second end, and a longitudinally extending fluid impermeable layer coupled to the fluid reservoir and the fluid outlet and defining a longitudinally elongated opening between the reservoir and the outlet. The assembly can further include a fluid permeable support disposed within the casing with a portion extending across the elongated opening, and a fluid permeable membrane disposed on the support and covering at least the portion of the support that extends across the elongated opening, so that the membrane is supported on the support and disposed across the elongated opening. The assembly can further include a tube having a first end disposed in the reservoir and a second, fluid discharge end.Type: ApplicationFiled: June 25, 2019Publication date: October 17, 2019Inventors: Robert A. Sanchez, Camille R. Newton, Joseph M. Forehand, Raymond J. Newton
-
Patent number: 10390989Abstract: A system suitable for collecting and transporting urine away from the body of a person or animal may include an assembly having a fluid impermeable casing having a fluid reservoir at a first end, a fluid outlet at a second end, and a longitudinally extending fluid impermeable layer coupled to the fluid reservoir and the fluid outlet and defining a longitudinally elongated opening between the reservoir and the outlet. The assembly can further include a fluid permeable support disposed within the casing with a portion extending across the elongated opening, and a fluid permeable membrane disposed on the support and covering at least the portion of the support that extends across the elongated opening, so that the membrane is supported on the support and disposed across the elongated opening. The assembly can further include a tube having a first end disposed in the reservoir and a second, fluid discharge end.Type: GrantFiled: September 8, 2016Date of Patent: August 27, 2019Assignee: PUREWICK CORPORATIONInventors: Robert A. Sanchez, Camille R. Newton, Joseph M. Forehand, Raymond J. Newton
-
Publication number: 20190255064Abstract: This invention relates to the use of benzimidazole derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3? OH kinase family (hereinafter PI3 kinases), suitably, PI3K?, PI3K?, PI3K?, and/or PI3K?. Suitably, the present invention relates to the use of benzimidazoles in the treatment of one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries. More suitably, the present invention relates to PI3K? selective benzimidazoles compounds for treating cancer.Type: ApplicationFiled: April 24, 2019Publication date: August 22, 2019Inventors: Rosanna TEDESCO, Junya QU, Robert SANCHEZ, Ralph A. RIVERO
-
Publication number: 20190224036Abstract: A system suitable for collecting and transporting urine away from the body of a person or animal may include an assembly having a fluid impermeable casing having a fluid reservoir at a first end, a fluid outlet at a second end, and a longitudinally extending fluid impermeable layer coupled to the fluid reservoir and the fluid outlet and defining a longitudinally elongated opening between the reservoir and the outlet. The assembly can further include a fluid permeable support disposed within the casing with a portion extending across the elongated opening, and a fluid permeable membrane disposed on the support and covering at least the portion of the support that extends across the elongated opening, so that the membrane is supported on the support and disposed across the elongated opening. The assembly can further include a tube having a first end disposed in the reservoir and a second, fluid discharge end.Type: ApplicationFiled: March 29, 2019Publication date: July 25, 2019Inventors: Robert A. Sanchez, Camille R. Newton, Joseph M. Forehand, Raymond J. Newton
-
Publication number: 20190216774Abstract: The present invention relates to pyrrolidine sulfonamide analogs, pharmaceutical compositions containing them and their use as TRPV4 antagonists.Type: ApplicationFiled: September 20, 2017Publication date: July 18, 2019Inventors: Edward J. BRNARDIC, Carl A. BROOKS, Brian Griffin LAWHORN, Guosen YE, Lisa S. BARTON, Brian W. BUDZIK, Jay M. MATTHEWS, John Jeffrey McATEE, Jacyln R. PATTERSON, Joseph E. PERO, Robert SANCHEZ, Matthew Robert SENDER, Lamont Roscoe TERRELL, David J. BEHM, James V. THOMAS
-
Patent number: 10314845Abstract: This invention relates to the use of benzimidazole derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3? OH kinase family (hereinafter PI3 kinases), suitably, PI3K?, PI3K?, PI3K?, and/or PI3K?. Suitably, the present invention relates to the use of benzimidazoles in the treatment of one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries. More suitably, the present invention relates to PI3K? selective benzimidazoles compounds for treating cancer.Type: GrantFiled: January 9, 2018Date of Patent: June 11, 2019Assignee: GlaxoSmithKline LLCInventors: Rosanna Tedesco, Junya Qu, Robert Sanchez, Ralph A. Rivero
-
Publication number: 20190142624Abstract: A system suitable for collecting and transporting urine away from the body of a person or animal may include an assembly having a fluid impermeable casing having a fluid reservoir at a first end, a fluid outlet at a second end, and a longitudinally extending fluid impermeable layer coupled to the fluid reservoir and the fluid outlet and defining a longitudinally elongated opening between the reservoir and the outlet. The assembly can further include a fluid permeable support disposed within the casing with a portion extending across the elongated opening, and a fluid permeable membrane disposed on the support and covering at least the portion of the support that extends across the elongated opening, so that the membrane is supported on the support and disposed across the elongated opening. The assembly can further include a tube having a first end disposed in the reservoir and a second, fluid discharge end.Type: ApplicationFiled: January 11, 2019Publication date: May 16, 2019Inventors: Robert A. Sanchez, Camille R. Newton, Joseph M. Forehand, Raymond J. Newton
-
Patent number: 10226376Abstract: A system suitable for collecting and transporting urine away from the body of a person or animal may include an assembly having a fluid impermeable casing having a fluid reservoir at a first end, a fluid outlet at a second end, and a longitudinally extending fluid impermeable layer coupled to the fluid reservoir and the fluid outlet and defining a longitudinally elongated opening between the reservoir and the outlet. The assembly can further include a fluid permeable support disposed within the casing with a portion extending across the elongated opening, and a fluid permeable membrane disposed on the support and covering at least the portion of the support that extends across the elongated opening, so that the membrane is supported on the support and disposed across the elongated opening. The assembly can further include a tube having a first end disposed in the reservoir and a second, fluid discharge end.Type: GrantFiled: June 1, 2017Date of Patent: March 12, 2019Assignee: PUREWICK CORPORATIONInventors: Robert A. Sanchez, Camille R. Newton, Joseph M. Forehand, Raymond J. Newton
-
Publication number: 20180263994Abstract: This invention relates to the use of benzimidazole derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3? OH kinase family (hereinafter PI3 kinases), suitably, PI3K?, PI3K?, PI3K?, and/or PI3K?. Suitably, the present invention relates to the use of benzimidazoles in the treatment of one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries. More suitably, the present invention relates to PI3K? selective benzimidazoles compounds for treating cancer.Type: ApplicationFiled: January 9, 2018Publication date: September 20, 2018Inventors: Rosanna TEDESCO, Junya QU, Robert SANCHEZ, Ralph A. RIVERO
-
Patent number: 9872860Abstract: This invention relates to the use of benzimidazole derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3? OH kinase family (hereinafter PI3 kinases), suitably, PI3K?, PI3K?, PI3K?, and/or PI3K?. Suitably, the present invention relates to the use of benzimidazoles in the treatment of one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries. More suitably, the present invention relates to PI3K? selective benzimidazoles compounds for treating cancer.Type: GrantFiled: September 3, 2015Date of Patent: January 23, 2018Assignee: GLAXOSMITHKLINE LLCInventors: Junya Qu, Ralph A. Rivero, Robert Sanchez, Rosanna Tedesco
-
Publication number: 20170266031Abstract: A system suitable for collecting and transporting urine away from the body of a person or animal may include an assembly having a fluid impermeable casing having a fluid reservoir at a first end, a fluid outlet at a second end, and a longitudinally extending fluid impermeable layer coupled to the fluid reservoir and the fluid outlet and defining a longitudinally elongated opening between the reservoir and the outlet. The assembly can further include a fluid permeable support disposed within the casing with a portion extending across the elongated opening, and a fluid permeable membrane disposed on the support and covering at least the portion of the support that extends across the elongated opening, so that the membrane is supported on the support and disposed across the elongated opening. The assembly can further include a tube having a first end disposed in the reservoir and a second, fluid discharge end.Type: ApplicationFiled: June 1, 2017Publication date: September 21, 2017Applicant: PUREWICK CORPORATIONInventors: Robert A. SANCHEZ, Camille R. NEWTON, Joseph M. FOREHAND, Raymond J. NEWTON
-
Publication number: 20170252202Abstract: A container for collecting liquid for transport, comprising: a web of flexible porous material defining at least a portion of a chamber in which liquid can be collected for transport. The chamber is configured to receive a tube in a position within the chamber that enables the tube to transport liquid from the chamber while the liquid collects within the chamber upon being drawn through the web when a partial vacuum is applied within the chamber via the tube. The porous material comprises a web of spun plastic fibers, such as spun polyester fibers. In one embodiment, the web of spun plastic fibers is configured to define an elongated portion of the chamber. In another embodiment, a backing of non-permeable material covers a portion of the web and is so combined with the web as to further define the chamber.Type: ApplicationFiled: November 25, 2015Publication date: September 7, 2017Applicant: PureWick CorporationInventors: ROBERT A. SANCHEZ, RAYMOND JOHN NEWTON
-
Publication number: 20170143534Abstract: A container for collecting liquid for transport, comprising: a web of flexible porous material defining at least a portion of a chamber in which liquid can be collected for transport. The chamber is configured to receive a tube in a position within the chamber that enables the tube to transport liquid from the chamber while the liquid collects within the chamber upon being drawn through the web when a partial vacuum is applied within the chamber via the tube. The porous material comprises a web of spun plastic fibers, such as spun polyester fibers. In one embodiment, the web of spun plastic fibers is configured to define an elongated portion of the chamber. In another embodiment, a backing of non-permeable material covers a portion of the web and is so combined with the web as to further define the chamber.Type: ApplicationFiled: November 25, 2015Publication date: May 25, 2017Applicant: PureWick CorporationInventor: Robert A. Sanchez
-
Publication number: 20170112844Abstract: This invention relates to the use of benzimidazole derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3? OH kinase family (hereinafter PI3 kinases), suitably, PI3K?, PI3K?, PI3K?, and/or PI3K?. Suitably, the present invention relates to the use of benzimidazoles in the treatment of one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries. More suitably, the present invention relates to PI3K? selective benzimidazoles compounds for treating cancer.Type: ApplicationFiled: September 3, 2015Publication date: April 27, 2017Inventors: Rosanna TEDESCO, Junya QU, Robert SANCHEZ, Ralph A. RIVERO
-
Patent number: 9615970Abstract: An intraocular pressure sensor system has a first pressure sensor located in an anterior chamber of an eye and a remote pressure sensor located remotely from the first pressure sensor. The remote pressure sensor measures or approximates atmospheric pressure. A difference between readings from the first pressure sensor and the remote pressure sensor approximates intraocular pressure.Type: GrantFiled: May 1, 2014Date of Patent: April 11, 2017Assignee: Alcon Research, Ltd.Inventors: Matthew Rickard, Robert Sanchez, Jr.
-
Patent number: D852820Type: GrantFiled: January 19, 2018Date of Patent: July 2, 2019Assignee: MOUTH PLAYER INC.Inventor: Robert Sanchez